<?xml version="1.0"?><rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2022, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Wed, 17 Mar 2021 15:59:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  424B3      Anchiano Therapeutics                </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Anchiano+Therapeutics++++++++++++++++/18142365.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Anchiano+Therapeutics++++++++++++++++/18142365.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Anchiano+Therapeutics++++++++++++++++/18142365.html</guid>
   <pubDate>Wed, 17 Mar 2021 15:59:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ANCN</category>
   	  </item>
  <item>
   <title>Form  8-K        Anchiano Therapeutics     For: Mar 15</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Anchiano+Therapeutics+++++For%3A+Mar+15/18138741.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Anchiano+Therapeutics+++++For%3A+Mar+15/18138741.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Anchiano+Therapeutics+++++For%3A+Mar+15/18138741.html</guid>
   <pubDate>Wed, 17 Mar 2021 06:04:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ANCN</category>
   	  </item>
  <item>
   <title>Chemomab Completes Merger with Anchiano Therapeutics</title>
   <link>http://www.streetinsider.com/Press+Releases/Chemomab+Completes+Merger+with+Anchiano+Therapeutics/18136602.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Chemomab+Completes+Merger+with+Anchiano+Therapeutics/18136602.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Chemomab+Completes+Merger+with+Anchiano+Therapeutics/18136602.html</guid>
   <pubDate>Tue, 16 Mar 2021 16:45:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.16853414</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37393068</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ANCN</category>
   	  </item>
  <item>
   <title>Chemomab Completes Merger with Anchiano Therapeutics</title>
   <link>http://www.streetinsider.com/Press+Releases/Chemomab+Completes+Merger+with+Anchiano+Therapeutics/18136602.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Chemomab+Completes+Merger+with+Anchiano+Therapeutics/18136602.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Chemomab+Completes+Merger+with+Anchiano+Therapeutics/18136602.html</guid>
   <pubDate>Tue, 16 Mar 2021 16:45:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.16853414</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37393068</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ANCN</category>
   	  </item>
  <item>
   <title>Chemomab Completes Merger with Anchiano Therapeutics</title>
   <link>http://www.streetinsider.com/Press+Releases/Chemomab+Completes+Merger+with+Anchiano+Therapeutics/18136602.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Chemomab+Completes+Merger+with+Anchiano+Therapeutics/18136602.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Chemomab+Completes+Merger+with+Anchiano+Therapeutics/18136602.html</guid>
   <pubDate>Tue, 16 Mar 2021 16:45:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.16853414</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37393068</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ANCN</category>
   	  </item>
  <item>
   <title>Chemomab Completes Merger with Anchiano Therapeutics</title>
   <link>http://www.streetinsider.com/PRNewswire/Chemomab+Completes+Merger+with+Anchiano+Therapeutics/18136602.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Chemomab+Completes+Merger+with+Anchiano+Therapeutics/18136602.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Chemomab+Completes+Merger+with+Anchiano+Therapeutics/18136602.html</guid>
   <pubDate>Tue, 16 Mar 2021 16:45:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.16853414</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37393068</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ANCN</category>
   	  </item>
  <item>
   <title>Chemomab Completes Merger with Anchiano Therapeutics</title>
   <link>http://www.streetinsider.com/PRNewswire/Chemomab+Completes+Merger+with+Anchiano+Therapeutics/18136602.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Chemomab+Completes+Merger+with+Anchiano+Therapeutics/18136602.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Chemomab+Completes+Merger+with+Anchiano+Therapeutics/18136602.html</guid>
   <pubDate>Tue, 16 Mar 2021 16:45:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.16853414</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37393068</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ANCN</category>
   	  </item>
  <item>
   <title>Chemomab Completes Merger with Anchiano Therapeutics</title>
   <link>http://www.streetinsider.com/PRNewswire/Chemomab+Completes+Merger+with+Anchiano+Therapeutics/18136602.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Chemomab+Completes+Merger+with+Anchiano+Therapeutics/18136602.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Chemomab+Completes+Merger+with+Anchiano+Therapeutics/18136602.html</guid>
   <pubDate>Tue, 16 Mar 2021 16:45:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.16853414</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37393068</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ANCN</category>
   	  </item>
  <item>
   <title>Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing</title>
   <link>http://www.streetinsider.com/Press+Releases/Anchiano+Announces+Shareholder+Approval+of+the+Merger+with+Chemomab+and+Prices+%2445.5M+Private+Financing/18130061.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Anchiano+Announces+Shareholder+Approval+of+the+Merger+with+Chemomab+and+Prices+%2445.5M+Private+Financing/18130061.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Anchiano+Announces+Shareholder+Approval+of+the+Merger+with+Chemomab+and+Prices+%2445.5M+Private+Financing/18130061.html</guid>
   <pubDate>Mon, 15 Mar 2021 17:54:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.37393068</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ANCN</category>
   	  </item>
  <item>
   <title>Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing</title>
   <link>http://www.streetinsider.com/Press+Releases/Anchiano+Announces+Shareholder+Approval+of+the+Merger+with+Chemomab+and+Prices+%2445.5M+Private+Financing/18130061.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Anchiano+Announces+Shareholder+Approval+of+the+Merger+with+Chemomab+and+Prices+%2445.5M+Private+Financing/18130061.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Anchiano+Announces+Shareholder+Approval+of+the+Merger+with+Chemomab+and+Prices+%2445.5M+Private+Financing/18130061.html</guid>
   <pubDate>Mon, 15 Mar 2021 17:54:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.37393068</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ANCN</category>
   	  </item>
  <item>
   <title>Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Anchiano+Announces+Shareholder+Approval+of+the+Merger+with+Chemomab+and+Prices+%2445.5M+Private+Financing/18130061.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Anchiano+Announces+Shareholder+Approval+of+the+Merger+with+Chemomab+and+Prices+%2445.5M+Private+Financing/18130061.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Anchiano+Announces+Shareholder+Approval+of+the+Merger+with+Chemomab+and+Prices+%2445.5M+Private+Financing/18130061.html</guid>
   <pubDate>Mon, 15 Mar 2021 17:54:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.37393068</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ANCN</category>
   	  </item>
  <item>
   <title>Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Anchiano+Announces+Shareholder+Approval+of+the+Merger+with+Chemomab+and+Prices+%2445.5M+Private+Financing/18130061.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Anchiano+Announces+Shareholder+Approval+of+the+Merger+with+Chemomab+and+Prices+%2445.5M+Private+Financing/18130061.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Anchiano+Announces+Shareholder+Approval+of+the+Merger+with+Chemomab+and+Prices+%2445.5M+Private+Financing/18130061.html</guid>
   <pubDate>Mon, 15 Mar 2021 17:54:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.37393068</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ANCN</category>
   	  </item>
  <item>
   <title>Form  4          Anchiano Therapeutics     For: Apr 23  Filed by: Polovets Stanislav</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Anchiano+Therapeutics+++++For%3A+Apr+23++Filed+by%3A+Polovets+Stanislav/18122486.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Anchiano+Therapeutics+++++For%3A+Apr+23++Filed+by%3A+Polovets+Stanislav/18122486.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Anchiano+Therapeutics+++++For%3A+Apr+23++Filed+by%3A+Polovets+Stanislav/18122486.html</guid>
   <pubDate>Fri, 12 Mar 2021 16:28:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ANCN</category>
   	  </item>
  <item>
   <title>Form  3          Anchiano Therapeutics     For: Apr 23  Filed by: Polovets Stanislav</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Anchiano+Therapeutics+++++For%3A+Apr+23++Filed+by%3A+Polovets+Stanislav/18122479.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Anchiano+Therapeutics+++++For%3A+Apr+23++Filed+by%3A+Polovets+Stanislav/18122479.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Anchiano+Therapeutics+++++For%3A+Apr+23++Filed+by%3A+Polovets+Stanislav/18122479.html</guid>
   <pubDate>Fri, 12 Mar 2021 16:27:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ANCN</category>
   	  </item>
  <item>
   <title>Form  3          Anchiano Therapeutics     For: Oct 20  Filed by: Fine Andrew</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Anchiano+Therapeutics+++++For%3A+Oct+20++Filed+by%3A+Fine+Andrew/18117751.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Anchiano+Therapeutics+++++For%3A+Oct+20++Filed+by%3A+Fine+Andrew/18117751.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Anchiano+Therapeutics+++++For%3A+Oct+20++Filed+by%3A+Fine+Andrew/18117751.html</guid>
   <pubDate>Thu, 11 Mar 2021 18:34:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ANCN</category>
   	  </item>
  <item>
   <title>Form  4          Anchiano Therapeutics     For: Apr 23  Filed by: Cohen Neil Harris</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Anchiano+Therapeutics+++++For%3A+Apr+23++Filed+by%3A+Cohen+Neil+Harris/18117747.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Anchiano+Therapeutics+++++For%3A+Apr+23++Filed+by%3A+Cohen+Neil+Harris/18117747.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Anchiano+Therapeutics+++++For%3A+Apr+23++Filed+by%3A+Cohen+Neil+Harris/18117747.html</guid>
   <pubDate>Thu, 11 Mar 2021 18:33:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ANCN</category>
   	  </item>
  <item>
   <title>Form  3          Anchiano Therapeutics     For: Apr 23  Filed by: Cohen Neil Harris</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Anchiano+Therapeutics+++++For%3A+Apr+23++Filed+by%3A+Cohen+Neil+Harris/18117739.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Anchiano+Therapeutics+++++For%3A+Apr+23++Filed+by%3A+Cohen+Neil+Harris/18117739.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Anchiano+Therapeutics+++++For%3A+Apr+23++Filed+by%3A+Cohen+Neil+Harris/18117739.html</guid>
   <pubDate>Thu, 11 Mar 2021 18:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ANCN</category>
   	  </item>
  <item>
   <title>Form  8-K        Anchiano Therapeutics     For: Mar 09</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Anchiano+Therapeutics+++++For%3A+Mar+09/18105384.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Anchiano+Therapeutics+++++For%3A+Mar+09/18105384.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Anchiano+Therapeutics+++++For%3A+Mar+09/18105384.html</guid>
   <pubDate>Wed, 10 Mar 2021 06:04:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ANCN</category>
   	  </item>
 </channel>
</rss>
